130 related articles for article (PubMed ID: 3399005)
21. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of alprostadil (prostaglandin E1) incorporated in lipid microspheres of soybean oil on intimal hyperplasia following balloon injury in rabbits.
Kunihara M; Tsuchida K; Kaneko K; Suga H; Hasegawa T; Mochizuki S; Kawai K; Shiga A; Yamaguchi T
Arzneimittelforschung; 2002; 52(5):358-64. PubMed ID: 12087920
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E1 and carbon dioxide reactivity during cerebral aneurysm surgery.
Abe K; Demizu A; Kamada K; Shimada Y; Sakaki T; Yoshiya I
Can J Anaesth; 1992 Mar; 39(3):247-52. PubMed ID: 1551156
[TBL] [Abstract][Full Text] [Related]
24. [The effects of ticlopidine and nicardipine on the prevention of symptomatic vasospasm after aneurysmal rupture].
Fujita K; Yamashita H; Masumura M; Ehara K; Tamaki N; Matsumoto S
No Shinkei Geka; 1988 May; 16(6):741-6. PubMed ID: 3412560
[TBL] [Abstract][Full Text] [Related]
25. The effect of prostaglandin E1 on local cerebral blood flow during cerebral-aneurysm clip ligation.
Abe K; Fujino Y; Demizu A; Takauchi Y; Hoshida T; Kamada K; Mashimo T; Yoshiya I
Eur J Anaesthesiol; 1991 Sep; 8(5):359-63. PubMed ID: 1935924
[TBL] [Abstract][Full Text] [Related]
26. [Studies on antinephritic effect of lipo PGE1 (1). Effect of lipo PGE1 on crescentic-type anti-GBM nephritis in rats].
Nagao T; Hattori T; Ito M; Suzuki Y
Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):247-56. PubMed ID: 2062010
[TBL] [Abstract][Full Text] [Related]
27. [Studies on antinephritic effect of Lipo PGE1 (2). The suppressive action of Lipo PGE1 on the development of accelerated passive Heymann nephritis in rats].
Nagao T; Ito M; Suzuki Y
Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1071-9. PubMed ID: 1725534
[TBL] [Abstract][Full Text] [Related]
28. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
[TBL] [Abstract][Full Text] [Related]
29. Carbon dioxide reactivity during prostaglandin E1 induced hypotension for cerebral aneurysm surgery.
Abe K; Demizu A; Mima T; Kamada K; Yoshiya I
Can J Anaesth; 1992 Mar; 39(3):253-9. PubMed ID: 1551157
[TBL] [Abstract][Full Text] [Related]
30. Effects of prostaglandin E1 or trimethaphan on local cerebral blood flow and carbon dioxide reactivity during cerebral aneurysm surgery.
Abe K; Yoshiya I
J Neurosurg Anesthesiol; 1993 Jul; 5(3):143-50. PubMed ID: 8400752
[TBL] [Abstract][Full Text] [Related]
31. Liposomal prostaglandin E1 enhances optic nerve head blood flow in cats.
Kitanishi K; Harino S; Suzuki M; Okamoto N; Reinach P
J Ocul Pharmacol Ther; 2001 Apr; 17(2):115-22. PubMed ID: 11324979
[TBL] [Abstract][Full Text] [Related]
32. Local cerebral blood flow with prostaglandin E1 or trimethaphan during cerebral aneurysm clip ligation.
Abe K; Demizu A; Kamada K; Morimoto T; Sakaki T; Yoshiya I
Can J Anaesth; 1991 Oct; 38(7):831-6. PubMed ID: 1742816
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
Hong L; Zhang J; Shen J
J Diabetes Complications; 2015; 29(8):1283-6. PubMed ID: 26355026
[TBL] [Abstract][Full Text] [Related]
34. [Effects of prostaglandin E1 on cerebral blood flow, cerebrospinal fluid pressure, and spinal subarachnoidal compliance].
Sugimoto N; Shudo Y; Takagi Y
Masui; 1990 Dec; 39(12):1632-6. PubMed ID: 2098590
[TBL] [Abstract][Full Text] [Related]
35. Antifibrinolytic therapy and cerebral vasospasm.
Haley EC; Torner JC; Kassell NF
Neurosurg Clin N Am; 1990 Apr; 1(2):349-56. PubMed ID: 2136147
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of thrombocytopenia associated with hemorrhagic cerebrovascular diseases].
Koide K; Manaka S; Takagi K; Kitamura T; Hirakawa M; Sashida J; Nomaguchi S
No Shinkei Geka; 1991 Aug; 19(8):729-34. PubMed ID: 1896116
[TBL] [Abstract][Full Text] [Related]
37. Accumlation of lipoprostaglandin E1 at the anastomotic region after systemic application.
Okochi M; Ueda K; Kajikawa A
Microsurgery; 2011 Jul; 31(5):382-7. PubMed ID: 21618280
[TBL] [Abstract][Full Text] [Related]
38. Lipo-prostaglandin E1 increases immediate arterial maximal flow velocity of free flap in patients undergoing reconstructive surgery.
Jin SJ; Suh HP; Lee J; Hwang JH; Hong JPJ; Kim YK
Acta Anaesthesiol Scand; 2019 Jan; 63(1):40-45. PubMed ID: 30058113
[TBL] [Abstract][Full Text] [Related]
39. Effect of prostaglandin E1-induced hypotension on carbon dioxide reactivity and local cerebral blood flow after subarachnoid haemorrhage.
Abe K; Demizu A; Yoshiya I
Br J Anaesth; 1992 Mar; 68(3):268-71. PubMed ID: 1547050
[TBL] [Abstract][Full Text] [Related]
40. Long beneficial effects after lipo-prostaglandin E1 administration on the ischemic gastric tube in pigs.
Ikeda Y; Morita N
Dis Esophagus; 2008; 21(8):765-9. PubMed ID: 18564164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
